Updated:
Aurelia Private Equity
Aurelia Private Equity invests in technology companies in information and telecommunications, medicine, and industry innovations.
Aurelia Private Equity
Aurelia Private Equity invests in technology companies in information and telecommunications, medicine, and industry innovations. They target businesses with strong management and scalable products. The firm has made 17 investments, including a Seed VC investment in SysGit on September 12, 2023, and has facilitated 5 portfolio exits, including Hematris Wound Care on July 05, 2023.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Germany
City
Frankfurt
Corporate office
Frankfurt, Germany
Sector focus
Frequently asked questions
What is Aurelia Private Equity's core investment strategy?
Aurelia pursues majority buyouts and growth equity in founder-led small and medium-sized enterprises across Germany, Austria, and Switzerland. The firm specializes in succession situations, where retiring owners lack internal management to continue the business. Target companies typically generate €10–50 million in revenue and operate in knowledge-intensive services, niche industrial technology, or enterprise software. The strategy combines operational transformation with a buy-and-build consolidation thesis within fragmented subsectors.
How does Aurelia source its deals?
Aurelia's deal flow relies heavily on direct relationships with Mittelstand founders, regional M&A advisors, and chambers of commerce—the traditional backbone of German private-company transactions. The firm does not lead with auction processes but prefers proprietary, pre-emptive negotiations with owners who prioritize cultural fit and operational continuity over the highest bid. This sourcing posture is critical in a region where trust and discretion often determine transaction outcomes more than purchase price.
What type of companies does Aurelia specifically avoid?
Aurelia avoids pure-play consumer brands, hardware manufacturing with heavy capital-expenditure requirements, and heavily unionized industrial assets. The firm does not back biotech or pharmaceutical development-stage companies. It also stays away from turnaround situations involving distressed debt or near-term liquidity crises, preferring fundamentally healthy businesses that require professionalization rather than financial restructuring.
What is Aurelia's geographic footprint?
The firm's primary investment focus is the DACH region—Germany, Austria, and Switzerland. From this core, portfolio companies are actively expanded into neighboring European markets, particularly Benelux and the Nordic countries. Aurelia operates from a single office in Frankfurt and does not maintain foreign subsidiaries, relying instead on the operating partners embedded within portfolio companies to drive international growth.
How is Aurelia different from other DACH-focused small-cap managers?
Aurelia's operating partner model sets it apart. Within 100 days of closing, the firm places a full-time, salaried executive into the acquired company to serve as CFO, COO, or Chief Transformation Officer. This is not a consulting engagement—the individual works inside the business daily. The approach is atypical in the European lower mid-market, where most firms rely on quarterly board meetings and light-touch portfolio management. It allows Aurelia to convert founder-led cultures into institutional-grade operations faster than peers using only external advisory support.
Who are Aurelia's limited partners?
Aurelia raises capital from a concentrated group of European institutional investors. The known limited-partner base includes German pension funds, Swiss and Austrian insurance companies, and a small number of European family offices. The firm does not market to US public pensions or sovereign wealth funds. Co-investment rights are offered selectively to existing limited partners on a deal-by-deal basis, without a formal co-investment fund vehicle.
Does Aurelia invest in venture-stage companies?
No. Although early-stage tags appear in some data-aggregator classifications, Aurelia's confirmed strategy targets revenue-generating, cash-flow-positive businesses. Minimum revenue thresholds exclude true venture-stage companies. The firm's growth capital mandate is reserved for profitable companies seeking capital to enter new geographies, acquire competitors, or scale an established service line.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: